Altered cognitive function in men treated for prostate cancer with leutinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled study
- PMID: 12641101
Altered cognitive function in men treated for prostate cancer with leutinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled study
Comment on
-
Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.BJU Int. 2002 Sep;90(4):427-32. doi: 10.1046/j.1464-410x.2002.02917.x. BJU Int. 2002. PMID: 12175403 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources